As of 2026-05-28, the EV/EBITDA ratio of Fresenius Medical Care AG & Co KGaA (FME.DE) is 6.42. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. FME.DE's latest enterprise value is 20,672.84 mil EUR. FME.DE's TTM EBITDA according to its financial statements is 3,217.76 mil EUR. Dividing these 2 quantities gives us the above FME.DE EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 5.8x - 8.0x | 6.7x |
| Forward P/E multiples | 9.2x - 13.5x | 11.2x |
| Fair Price | 29.80 - 79.90 | 50.22 |
| Upside | -19.7% - 115.4% | 35.4% |
| Date | EV/EBITDA |
| 2026-05-27 | 6.42 |
| 2026-05-26 | 6.44 |
| 2026-05-25 | 6.47 |
| 2026-05-22 | 6.44 |
| 2026-05-21 | 6.58 |
| 2026-05-20 | 6.55 |
| 2026-05-19 | 6.54 |
| 2026-05-18 | 6.52 |
| 2026-05-15 | 6.44 |
| 2026-05-14 | 6.42 |
| 2026-05-13 | 6.37 |
| 2026-05-12 | 6.48 |
| 2026-05-11 | 6.44 |
| 2026-05-08 | 6.45 |
| 2026-05-07 | 6.43 |
| 2026-05-06 | 6.31 |
| 2026-05-05 | 6.21 |
| 2026-05-04 | 6.59 |
| 2026-04-30 | 6.56 |
| 2026-04-29 | 6.51 |
| 2026-04-28 | 6.57 |
| 2026-04-27 | 6.58 |
| 2026-04-24 | 6.58 |
| 2026-04-23 | 6.60 |
| 2026-04-22 | 6.62 |
| 2026-04-21 | 6.65 |
| 2026-04-20 | 6.64 |
| 2026-04-17 | 6.65 |
| 2026-04-16 | 6.59 |
| 2026-04-15 | 6.57 |
| 2026-04-14 | 6.66 |
| 2026-04-13 | 6.69 |
| 2026-04-10 | 6.72 |
| 2026-04-09 | 6.69 |
| 2026-04-08 | 6.71 |
| 2026-04-07 | 6.61 |
| 2026-04-02 | 6.57 |
| 2026-04-01 | 6.56 |
| 2026-03-31 | 6.56 |
| 2026-03-30 | 6.59 |
| 2026-03-27 | 6.56 |
| 2026-03-26 | 6.59 |
| 2026-03-25 | 6.54 |
| 2026-03-24 | 6.50 |
| 2026-03-23 | 6.46 |
| 2026-03-20 | 6.48 |
| 2026-03-19 | 6.53 |
| 2026-03-18 | 6.63 |
| 2026-03-17 | 6.71 |
| 2026-03-16 | 6.68 |